Key facts
- This page summarizes BARCLAYS PLC's Form 3 filing for Pyxis Oncology, Inc. (PYXS).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 26 Apr 2022, 13:40.
BARCLAYS PLC - 25 Apr 2022 Form 3 Insider Report for Pyxis Oncology, Inc. (PYXS)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- PYXS
- Reported as of
- 25 Apr 2022
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 26 Apr 2022, 13:40:50 UTC
- Prior SEC filing
- 09 Mar 2022
- Next SEC filing
- 27 Apr 2022
- Source filing
- View source filing
- Reporting owner signature
- Suejean Mott
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
BARCLAYS PLC filed Form 3 for Pyxis Oncology, Inc. (PYXS) on 26 Apr 2022.
Change
- Previous filing in this sequence was filed on 09 Mar 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PYXS
holding
Common Stock, par value $0.001 per share
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,477,945
- Date
- 25 Apr 2022
- Ownership
- By Barclays Bank PLC
PYXS
holding
Common Stock, par value $0.001 per share
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 30
- Date
- 25 Apr 2022
- Ownership
- By Barclays Capital Inc.
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
SEC remarks
(a) Beneficially owned Class A ordinary shares are comprised in Units, each consisting of one class A ordinary share (b) Name of Person Filing: (1) Barclays PLC (2) Barclays Bank PLC (controlled by Barclays PLC) (3) Barclays Capital Inc. (controlled by Barclays PLC) (c) Address of Principal Business Office or, if none, Residence: (1) Barclays PLC 1 Churchill Place London, E14 5HP, England (2) Barclays Bank PLC 1 Churchill Place London, E14 5HP, England (3) Barclays Capital Inc. 745 Seventh Avenue New York, New York 10019 United States